Pharmaceutical Executive September 15, 2021
Mark Miller

Mari, a 45-year-old woman who has just begun her treatment for diabetes, receives an invitation to a patient support group as well as meal planning tools. Ralph, who has been on his medication for nearly a year, gets information about a program that could lower his out-of-pocket costs. And Aarav, who is concerned that his therapies may no longer be working effectively, is offered a symptom tracker and compliance tips.

These are examples of empathetic and meaningful brand engagement that pharmaceutical leaders strive to deliver to customers throughout their patient journey. But what customers often receive instead are disconnected, one-off interactions that don’t meet their specific needs, and don’t promote long-term relationships or ongoing dialogues with their pharmaceutical providers.

In...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Biotechnology, Pharma, Pharma / Biotech, Technology
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders
Unlocking Targeted Cancer Care: Biomarkers as the Key to Personalized Treatments

Share This Article